Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure

ABSTRACT The Centers for Disease Control and Prevention (CDC) categorized carbapenem-resistant Enterobacterales (CRE) infections as an “urgent” health care threat requiring public attention and research. Certain patients with CRE infections may be at higher risk for poor clinical outcomes than other...

Full description

Bibliographic Details
Main Authors: Nicholas Rebold, Abdalhamid M. Lagnf, Sara Alosaimy, Dana J. Holger, Paige Witucki, Andrew Mannino, Michelle Dierker, Kristen Lucas, Ashlan J. Kunz Coyne, Amer El Ghali, Kaylee E. Caniff, Michael P. Veve, Michael J. Rybak
Format: Article
Language:English
Published: American Society for Microbiology 2023-02-01
Series:Microbiology Spectrum
Subjects:
carbapenem resistance
Enterobacterales
risk factors
clinical failure
ceftazidime-avibactam
meropenem-vaborbactam
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02647-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.02647-22

Similar Items